A novel blue emitting phosphor Ca 1− y Sr y ScBO 4 :Bi 3+ with zero-thermal quenching for multi-scenario application
Dalton Transactions · 2024 · 53 (7) · 3356-3362
DOI: 10.1039/d3dt03734g ↗Kurz gefasst
Fachartikel in der Zeitschrift Dalton Transactions, 2024. Verfasst von Zekang Yan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Hebei Key Laboratory of Optic-electronic Information and Materials, China. li_panlai@126.com. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
A novel blue emitting phosphor, Ca 1− y Sr y ScBO 4 :Bi 3+ , exhibits zero-thermal quenching properties, making it a potential candidate for applications in plant lighting and biocontrol.
Autor:innen und Institutionen
- Hebei Key Laboratory of Optic-electronic Information and Materials, China. li_panlai@126.com.
- College of Physics Science & Technology, Hebei University, Baoding 071002, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yan, Z., Li, P., Gong, J., Liu, M., Feng, X., Zhang, T., Li, X., Guo, D., Suo, H., & Wang, Z. (2024). A novel blue emitting phosphor Ca 1− y Sr y ScBO 4 :Bi 3+ with zero-thermal quenching for multi-scenario application. Dalton Transactions, 53(7), 3356-3362. https://doi.org/10.1039/d3dt03734g
Vancouver
Yan Z, Li P, Gong J, Liu M, Feng X, Zhang T, et al. A novel blue emitting phosphor Ca 1− y Sr y ScBO 4 :Bi 3+ with zero-thermal quenching for multi-scenario application. Dalton Transactions. 2024;53(7):3356-3362. doi:10.1039/d3dt03734g
BibTeX
@article{Yan2024,
author = {Yan, Zekang and Li, Panlai and Gong, Jie and Liu, Mengdi and Feng, XiuXiu and Zhang, Ting and Li, Xiaojie and Guo, Dongxu and Suo, Hao and Wang, Zhijun},
title = {A novel blue emitting phosphor Ca 1− y Sr y ScBO 4 :Bi 3+ with zero-thermal quenching for multi-scenario application},
journal = {Dalton Transactions},
year = {2024},
volume = {53},
number = {7},
pages = {3356--3362},
doi = {10.1039/d3dt03734g}
}
EUVIMED